Home > Insider Trading > Filing (0000899243-21-014399)

Filing Details

Accession Number:: 0000899243-21-014399
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-04-01 18:43:29
Reporting Period:: 2021-03-16

Accepted Time:: 2021-04-01 18:43:29
Original Submission Date:: 2021-03-18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720580	Adicet Bio Inc.	ACET	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1340875	Chen Schor	C/O Adicet Bio, Inc. 500 Boylston Street, 13Th Floor Boston MA 02116	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-16	6,474	$15.07	155,218	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-16	5,395	$15.66	129,318	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-16	2,508	$15.07	152,710	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-16	2,089	$15.66	127,229	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-01-22	26,070	$0.00	0	No	5	G	Direct
Common Stock	Disposition	2021-01-22	22,985	$0.00	0	No	5	G	Indirect	See footnote
Common Stock	Disposition	2021-01-22	23,570	$0.00	0	No	5	G	Indirect	See footnote
Common Stock	Disposition	2021-01-25	19,286	$0.00	0	No	5	G	Indirect	See footnote
Common Stock	Disposition	2021-01-25	27,014	$0.00	0	No	5	G	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	5	G	Direct
No	5	G	Indirect	See footnote
No	5	G	Indirect	See footnote
No	5	G	Indirect	See footnote
No	5	G	Indirect	See footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive.
Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee.
Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee.
Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.